These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27637197)

  • 1. Use of Embryonic Stem Cells to Treat Severe Eye Diseases.
    Aznar J; Tudela J
    Cuad Bioet; 2016; 27(90):241-7. PubMed ID: 27637197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
    Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
    Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium.
    Ouyang H; Goldberg JL; Chen S; Li W; Xu GT; Li W; Zhang K; Nussenblatt RB; Liu Y; Xie T; Chan CC; Zack DJ
    Int J Mol Sci; 2016 Mar; 17(3):415. PubMed ID: 27102165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retinal cell therapy using iPS cells].
    Takahashi M
    Rinsho Shinkeigaku; 2013; 53(11):1016. PubMed ID: 24291864
    [No Abstract]   [Full Text] [Related]  

  • 5. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
    Leach LL; Clegg DO
    Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
    Ben M'Barek K; Habeler W; Monville C
    Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cell trials for macular degeneration: a preliminary report.
    Schwartz SD; Hubschman JP; Heilwell G; Franco-Cardenas V; Pan CK; Ostrick RM; Mickunas E; Gay R; Klimanskaya I; Lanza R
    Lancet; 2012 Feb; 379(9817):713-20. PubMed ID: 22281388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinal regeneration with iPS cells ‒ Clinical trials for retinal degenerative disorders].
    Sugita S
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):79-85. PubMed ID: 26016634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluripotent human stem cells for the treatment of retinal disease.
    Rowland TJ; Buchholz DE; Clegg DO
    J Cell Physiol; 2012 Feb; 227(2):457-66. PubMed ID: 21520078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell-based treatment in geographic atrophy: promises and pitfalls.
    Kvanta A; Grudzinska MK
    Acta Ophthalmol; 2014 Feb; 92(1):21-6. PubMed ID: 23890249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells in retinal regeneration: past, present and future.
    Ramsden CM; Powner MB; Carr AJ; Smart MJ; da Cruz L; Coffey PJ
    Development; 2013 Jun; 140(12):2576-85. PubMed ID: 23715550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative Medicine: Solution in Sight.
    Wang Q; Stern JH; Temple S
    Adv Exp Med Biol; 2016; 854():543-8. PubMed ID: 26427457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
    Hinkle JW; Mahmoudzadeh R; Kuriyan AE
    Stem Cell Res Ther; 2021 Oct; 12(1):538. PubMed ID: 34635174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem Cell Treatment for Age-Related Macular Degeneration: the Challenges.
    Singh MS; MacLaren RE
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD78-AMD82. PubMed ID: 30025109
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective Effects of Human iPS-Derived Retinal Pigmented Epithelial Cells in Comparison with Human Mesenchymal Stromal Cells and Human Neural Stem Cells on the Degenerating Retina in rd1 mice.
    Sun J; Mandai M; Kamao H; Hashiguchi T; Shikamura M; Kawamata S; Sugita S; Takahashi M
    Stem Cells; 2015 May; 33(5):1543-53. PubMed ID: 25728228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins.
    Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO
    J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cells as a treatment for macular degeneration.
    Pan CK; Heilweil G; Lanza R; Schwartz SD
    Expert Opin Biol Ther; 2013 Aug; 13(8):1125-33. PubMed ID: 23705996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
    Croze RH; Clegg DO
    Dev Ophthalmol; 2014; 53():81-96. PubMed ID: 24732763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cell-based therapy for age-related macular degeneration.
    Bracha P; Moore NA; Ciulla TA
    Expert Opin Biol Ther; 2017 Sep; 17(9):1113-1126. PubMed ID: 28664762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.